Work

Targeting NF-kB by Perifosine, Bortezomib and Rituximab in Waldenstrom Macroglobulinemia (WM).

Year: 2007

Type: article

Source: Blood

DOI: 10.1182/blood.v110.11.2512.2512

Authors: Xavier Leleu, Eeckhoute Jerome, Xiaoying Jia, Anne-Sophie Moreau, Aldo M. Roccaro, Mena Farag, Antonio Sacco, Evdoxia Hatjiharissi, Hai T. Ngo, Judith Runnels, Abdelkareem Azab, Feda Azab, Zachary Hunter, Peter Sportelli, Steven P. Treon, Teru Hideshima, Kenneth C. Anderson, Irene M. Ghobrial

Institutions: Harvard University, Centre Hospitalier Universitaire de Lille, Dana-Farber Cancer Institute

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2556052845

FWCI:

Cites:

Cited by:

Related to: 10